UNSPSC 51162004: Aminophylline/ephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162004 Aminophylline/ephedrine, a Commodity code, shows minimal recent state and local procurement activity directly aligned with its nominal scope. The two recent opportunities posted under this code involve naloxone procurement and on-site pharmacy services — neither of which centers on aminophylline or ephedrine as primary commodities. Seminole County, Florida issued an IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually), while Hall County, Georgia issued an RFQ/P for comprehensive on-site pharmacy services covering a formulary of 25 medications across multiple therapeutic categories. The mismatch between the code's nominal scope and the work actually being solicited suggests the code may be receiving catch-all or incorrectly tagged opportunities, limiting its relevance as a marker for true aminophylline or ephedrine purchasing demand.

The geographic spread of recent activity covers Florida and Georgia only, based on the two opportunities posted since early 2026. Seminole County's naloxone IFB (solicitation IFB60459723LAS) closed on July 26, 2023, with quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida; Hall County's pharmacy RFQ/P (#47-010) posted May 4, 2026, with sealed proposals due June 4, 2026, at 2:00 p.m. Eastern Time for an initial one-year term beginning January 1, 2027, with four optional one-year renewals. Neither opportunity explicitly addresses aminophylline or ephedrine as a line item, and the code's recent activity does not support a robust procurement signal for these products at the state and local level.